Preferred Label : dihydrotestosterone;
MeSH definition : A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the
enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.;
MeSH synonym : stanolone; 5-alpha-dht; androstanolone; 17beta hydroxy 5alpha androstan 3 one; 5 alpha dihydrotestosterone; 5 alpha-dihydrotestosterone; 5 alpha dht; 17beta-hydroxy-5alpha-androstan-3-one; 5-alpha dihydrotestosterone; dihydrotestosterone, 5-alpha;
CISMeF synonym : berenguer infale brand of androstanolone; Besins-Iscovesco brand of androstanolone; besins iscovesco brand of androstanolone; cuxson brand of androstanolone;
MeSH hyponym : gelovit; andractim; anaprotin;
Related MeSH term : dihydroepitestosterone; 5 beta-Dihydrotestosterone; 17 beta-Hydroxy-5 beta-Androstan-3-One; 5 beta Dihydrotestosterone; 17 beta Hydroxy 5 beta Androstan 3 One; beta-Hydroxy-5 beta-Androstan-3-One, 17;
MeSH CAS label : Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-;
MeSH Related Number : 521-18-6 (Dihydrotestosterone);
Registry Number MeSH : 521-18-6;
Wikipedia link : https://en.wikipedia.org/wiki/Dihydrotestosterone;
Codes EINECS : 208-307-3;
Is substance : O;
UNII : 08J2K08A3Y;
InChIKey : NVKAWKQGWWIWPM-ABEVXSGRSA-N;
Origin ID : D013196;
UMLS CUI : C0038148;
ATC code(s)
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Indexing information
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- RB 346 [MeSH Supplementary Concept]
- demalon [MeSH Supplementary Concept]
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Validated automatic mappings to NTBT
A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the
enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/andractim_-_ct-5775.pdf
http://www.has-sante.fr/portail/jcms/c_1014900/andractim
2010
France
French
dihydrotestosterone
androgens
androstanolone
administration, cutaneous
insurance, health, reimbursement
gynecomastia
treatment outcome
evaluation of the transparency committee
---
http://www.meddispar.fr/medicaments/3242873
2008
France
French
gels
administration, cutaneous
dihydrotestosterone
gynecomastia
drug prescriptions
legislation, drug
androstanolone
drug information
---